Cargando…
Distinguishing Incubation and Acute Disease Stages of Mild-to-Moderate COVID-19
While numerous studies have already compared the immune responses against SARS-CoV-2 in severely and mild-to-moderately ill COVID-19 patients, longitudinal trajectories are still scarce. We therefore set out to analyze serial blood samples from mild-to-moderately ill patients in order to define the...
Autores principales: | Müller, Michael, Volzke, Johann, Subin, Behnam, Schmidt, Christian Johann, Geerdes-Fenge, Hilte, Reisinger, Emil Christian, Müller-Hilke, Brigitte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875077/ https://www.ncbi.nlm.nih.gov/pubmed/35215797 http://dx.doi.org/10.3390/v14020203 |
Ejemplares similares
-
Single-dose SARS-CoV-2 vaccinations with either BNT162b2 or AZD1222 induce disparate Th1 responses and IgA production
por: Müller, Michael, et al.
Publicado: (2022) -
RE: ‘Streptococcus pluranimalium: A novel human pathogen?’
por: Pongratz, Peter, et al.
Publicado: (2017) -
COVID-19: Epidemiologische und klinische Fakten
por: Hemmer, Christoph J., et al.
Publicado: (2020) -
Vaccine-Induced T-Cell and Antibody Responses at 12 Months after Full Vaccination Differ with Respect to Omicron Recognition
por: Mai, Franz, et al.
Publicado: (2022) -
Higher SARS-CoV-2 Spike Binding Antibody Levels and Neutralization Capacity 6 Months after Heterologous Vaccination with AZD1222 and BNT162b2
por: Müller-Hilke, Brigitte, et al.
Publicado: (2022)